Easton Pharmaceuticals (Easton Pharmaceuticals) COGS-to-Revenue : 0.00 (As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Easton Pharmaceuticals COGS-to-Revenue?

Easton Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2021 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2021 was $0.00 Mil.

Easton Pharmaceuticals's COGS to Revenue for the three months ended in Sep. 2021 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Easton Pharmaceuticals's Gross Margin % for the three months ended in Sep. 2021 was N/A%.

Easton Pharmaceuticals COGS-to-Revenue Historical Data

The historical data trend for Easton Pharmaceuticals's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Easton Pharmaceuticals COGS-to-Revenue Chart

Easton Pharmaceuticals Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec18

Dec19

Dec20

COGS-to-Revenue

Get a 7-Day Free Trial

0.32

0.09

0.72

0.87

Easton Pharmaceuticals Quarterly Data
	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Dec03	Mar04	Jun04	Sep04	Dec04	Mar05	Jun05	Sep05	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Easton Pharmaceuticals COGS-to-Revenue Calculation

Easton Pharmaceuticals's COGS to Revenue for the fiscal year that ended in Dec. 2020 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Easton Pharmaceuticals's COGS to Revenue for the quarter that ended in Sep. 2021 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Easton Pharmaceuticals (OTCPK:EAPH) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Easton Pharmaceuticals's Gross Margin % for the three months ended in Sep. 2021 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Easton Pharmaceuticals COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Easton Pharmaceuticals's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Easton Pharmaceuticals (Easton Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Easton Pharmaceuticals Inc (OTCPK:EAPH) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

2 Bloor Street East, Suite 3500, Toronto, ON, CAN, M4W 1A8

Website

http://www.eastonpharmaceuticalsinc.com

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.